Home Capital Broker's Calls

Q&M continues to be a beneficiary of the pandemic; 'Buy' on share price weakness

Samantha Chiew
Samantha Chiew9/16/2021 3:2 PM GMT+08  • 3 min read
Q&M continues to be a beneficiary of the pandemic; 'Buy' on share price weakness
'Buy' Q&M on share price weakness as it has a sparkly white outlook.
Font Resizer
Share to WhatsappShare to FacebookShare to LinkedInMore Share
Scroll to top
Follow us on Facebook and join our Telegram channel for the latest updates.

The increase in Covid-19 cases in Singapore lately may be causing a stir in the community, but for dental group Q&M Dental, this is an opportunity.

As such, CGS-CIMB and Maybank Kim Eng have kept their “buy” calls on the stock with target price of 89 cents and 85 cents, respectively. Furthermore, the stock has pulled back by about 20% from its recent peak following its 2QFY2021 results on profit taking and general market weakness. Hence, this creates a buying opportunity for investors who missed the previous rally.

With cases as at Sept 16 reaching over 800 and expected to reach over 1,000 by the next week, Singapore is ramping up its testing frequency. This bodes well for the group’s Covid-19 testing arm Acumen.

For more insights on corporate trends...
Sign In or Create an account to access our premium content.
Subscription Entitlements:
Less than $9 per month
Unlimited access to latest and premium articles
3 Simultaneous logins across all devices
Bonus unlimited access to online articles and virtual newspaper on The Edge Malaysia (single login)
×
Loading next article...
The Edge Singapore
Download The Edge Singapore App
Google playApple store play
Keep updated
Follow our social media
Subscribe to The Edge Singapore
Get credible investing ideas from our in-depth stock analysis, interviews with key executives, corporate movements coverage and their impact on the market.
© 2022 The Edge Publishing Pte Ltd. All rights reserved.